Philips Medical v. Cardiac Science
This article was originally published in The Gray Sheet
Executive Summary
Philips Electronics' June patent infringement suit against Cardiac Science is dismissed by Seattle district court Sept. 3. Court determines Cardiac Science's patent suit filed against Philips in Minnesota on Feb. 12 takes priority over the Washington case, according to Cardiac Science. The suits relate to 10 U.S. patents for Cardiac Science's Powerheart automated external defibrillator (1"The Gray Sheet" Feb. 17, 2003, In Brief)...
You may also be interested in...
Cardiac Science v. Philips Medical
Automated external defibrillator patent suit filed Feb. 12 in Minnesota federal court alleges Philips' HeartStart AEDs infringe seven Cardiac Science patents related to the Powerheart AED. The suit follows Cardiac Science's successful litigation of AED maker Zoll last year, which involved one of the same patents for electrode packaging and ended in a settlement with a cross-license and payment of royalties...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.